Skip to main content

Swift Biosciences Accel-Amplicon Custom NGS Panels

Swift Biosciences has launched Accel-Amplicon Custom NGS Panels, a targeted DNA sequencing product that enables clinical researchers to rapidly design highly focused panels to discover, validate, and screen disease genes and their variants. The platform-agnostic panel supports a wide range of input sample types including fresh and fresh-frozen tissue, whole blood, blood spot cards, formalin-fixed paraffin-embedded tissue, cell-free DNA, circulating tumor DNA, buccal swabs, whole genome amplified DNA and purified DNA. The panels require 10 nanograms of sample input, and enables library prep in under two hours. Swift said that it also partnered with informatics firm Genialis to integrate alignment, trimming, QC, and variant calling into one simple pipeline.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.